(Q33922419)

30 July 2017

title

Schizophrenia: elevated mRNA for calcium-calmodulin-dependent protein kinase IIbeta in frontal cortex (English)

1 reference

30 July 2017

1 reference

Novak G

1

1 reference

30 July 2017

Seeman P

series ordinal

2

1 reference

30 July 2017

Tallerico T

series ordinal

3

1 reference

30 July 2017

publication date

1 October 2000

1 reference

30 July 2017

published in

Molecular Brain Research

1 reference

30 July 2017

volume

82

1 reference

30 July 2017

issue

1-2

1 reference

30 July 2017

page(s)

95-100

1 reference

Synaptic vesicle-associated Ca2+/calmodulin-dependent protein kinase II is a binding protein for synapsin I

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2800%2900188-1

7 January 2021

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2800%2900188-1

7 January 2021

The α-Ca2+/calmodulin kinase II: A bidirectional modulator of presynaptic plasticity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2800%2900188-1

7 January 2021

Synapsin I, an actin-binding protein regulating synaptic vesicle traffic in the nerve terminal.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2800%2900188-1

7 January 2021

Enhanced amphetamine- and K+-mediated dopamine release in rat striatum after repeated amphetamine: differential requirements for Ca2+- and calmodulin-dependent phosphorylation and synaptic vesicles.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2800%2900188-1

7 January 2021

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2800%2900188-1

7 January 2021

Increased dopamine transmission in schizophrenia: relationship to illness phases

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2800%2900188-1

7 January 2021

No linkage between D2 dopamine receptor gene region and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2800%2900188-1

7 January 2021

Schizophrenia: normal sequence in the dopamine D2 receptor region that couples to G-proteins. DNA polymorphisms in D2.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2800%2900188-1

7 January 2021

Rapid release of antipsychotic drugs from dopamine D2 receptors: an explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2800%2900188-1

7 January 2021

Enduring enhancement in frontal cortex dopamine utilization in an animal model of amphetamine psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2800%2900188-1

7 January 2021

10.1016/S0169-328X(00)00188-1

Identifiers

DOI

1 reference

30 July 2017

1 reference